181 related articles for article (PubMed ID: 3954378)
1. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
[TBL] [Abstract][Full Text] [Related]
2. [Effect of combined use of radiation and twice intratumor administration of OK-432 at one week intervals against a murine fibrosarcoma (NFSA)].
Mukai M; Ando K; Koike S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):631-5. PubMed ID: 3355184
[TBL] [Abstract][Full Text] [Related]
3. [Combined effect of the topical administration of OK-432 with radiation on the C3H mouse fibrosarcoma (NFSa)--TCD50 and the mechanism of action].
Mukai M; Ando K; Koike S; Nagao K; Isono K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3432-5. PubMed ID: 3789754
[TBL] [Abstract][Full Text] [Related]
4. [The effect of OK-432 on modifying a spontaneous lung metastasis from murine fibrosarcomas].
Ito H; Yamada S; Nishiguchi I; Shigematsu N; Nakayama T; Kuribayashi T; Hashimoto S
Gan No Rinsho; 1990 Aug; 36(9):993-7. PubMed ID: 2381054
[TBL] [Abstract][Full Text] [Related]
5. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
[TBL] [Abstract][Full Text] [Related]
7. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
[TBL] [Abstract][Full Text] [Related]
8. Effect of OK-432 on the lymphnode metastasis of MCA-sarcoma cell lines: a new therapeutic approach.
Inoh A; Kodama Y; Yokoro K
Hiroshima J Med Sci; 1989 Dec; 38(4):213-9. PubMed ID: 2637250
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the anti-tumor activity of direct current--an effective adjuvant therapy in irradiation].
Ito H; Hashimoto S
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1405-11. PubMed ID: 2786377
[TBL] [Abstract][Full Text] [Related]
10. Effect of combination therapy of radiation and local administration of OK-432 on a murine fibrosarcoma.
Mukai M; Ando K; Koike S; Nagao K
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):125-30. PubMed ID: 2745186
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide].
Norimura T; Kunugita N; Dohi S; Mukae S; Tsuchiya T
Gan No Rinsho; 1988 Oct; 34(13):1811-5. PubMed ID: 3199515
[TBL] [Abstract][Full Text] [Related]
12. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
[TBL] [Abstract][Full Text] [Related]
13. [Modification of spontaneous lung metastasis by local radiation combined with or without immunomodifier].
Shigematsu N
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Sep; 50(9):1139-46. PubMed ID: 2247355
[TBL] [Abstract][Full Text] [Related]
14. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
[TBL] [Abstract][Full Text] [Related]
15. [Tumor immunity induced by local radiotherapy].
Yamashita T; Hayakawa Y; Hanajima K; Mochizuki S
Gan No Rinsho; 1983 Oct; 29(13):1506-11. PubMed ID: 6422094
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
18. Independent effect of a mixed-beam regimen of fast neutrons and gamma rays on a murine fibrosarcoma.
Ando K; Koike S; Fukuda N; Kanehira C
Radiat Res; 1984 Apr; 98(1):96-106. PubMed ID: 6718698
[TBL] [Abstract][Full Text] [Related]
19. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
20. [New combined therapy of radiation and local administration of OK-432 for esophageal cancer--local control rate and two-year survival rate].
Mukai M; Morita S; Tsunemoto H
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):94-7. PubMed ID: 2324590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
